This ignores the economics. If you look to the FDA as the template, the strict testing regime and the cost of navigating through the process ensures that only patent-protected drugs ever get approved for human medical use.
I extrapolate, perhaps inappropriately, that the combination of an FAA ban on commercial drones and a testing initiative will mean that only proprietary, patent-protected, and closed-source drones--and their software packages--will ever have access to this potentially interesting and useful market.
And that barrier to entry will make everything more expensive, in the same way that a GPS becomes more expensive when installed in an avionics panel than when it is strapped to the pilot's thigh.
Premature optimization is not optimization at all.
I extrapolate, perhaps inappropriately, that the combination of an FAA ban on commercial drones and a testing initiative will mean that only proprietary, patent-protected, and closed-source drones--and their software packages--will ever have access to this potentially interesting and useful market.
And that barrier to entry will make everything more expensive, in the same way that a GPS becomes more expensive when installed in an avionics panel than when it is strapped to the pilot's thigh.
Premature optimization is not optimization at all.